CD4 and myeloid sarcoma: Immune cell function is impacted and MS development is aided by hyper- or hypomethylation in important immune-related genes, such as HLA-DRB1 in CD4 + T cells and IFN-γ/IL-17a in CD44 + encephalitogenic T cells [40].